Identification and early anticoagulation in patients with atrial fibrillation in the emergency department

Kim Schwab1, Richard Smith2, Eric Wager3

  • 1Sharp Chula Vista Medical Center, Chula Vista, CA, United States of America.

Insights

A multidisciplinary team approach significantly improved guideline-recommended anticoagulation prescribing for atrial fibrillation patients in the emergency department, closing a critical treatment gap for stroke prevention.

Area of Science:

  • Cardiology
  • Emergency Medicine
  • Pharmacology

Background:

  • Emergency departments (ED) encounter over 500,000 atrial fibrillation (AF) visits annually in the US.
  • Guideline-recommended anticoagulation is underprescribed in less than 55% of eligible AF patients.
  • A significant treatment gap exists in anticoagulation therapy for AF patients presenting to the ED.

Purpose of the Study:

  • To measure guideline-recommended anticoagulation prescribing in nonvalvular atrial fibrillation (NVAF) patients in the ED.
  • To assess the effectiveness of a multidisciplinary team approach in closing the anticoagulation treatment gap.
  • To compare anticoagulation prescribing between routine care and a multidisciplinary team intervention.

Main Methods:

  • An observational, prospective cohort study design was employed.
  • CHA2DS2-VASc and HAS-BLED scores determined guideline-based oral anticoagulation (OAC) compliance.
  • A multidisciplinary team approach with Transition of Care (TOC) services was compared to routine care (baseline cohort).

Main Results:

  • Guideline-based OAC discharge rates were 62.3% in the baseline cohort (n=99) versus 87.8% in the multidisciplinary team cohort (n=131).
  • The multidisciplinary approach resulted in a 25.5% improvement in appropriate anticoagulation prescribing (p < .001).
  • This improvement was statistically significant, with a 95% confidence interval of (0.14-0.37).

Conclusions:

  • A multidisciplinary team approach, including TOC services, enhances identification and early intervention for NVAF patients at stroke risk in the ED.
  • This strategy significantly increases the proportion of moderate to high-risk patients discharged with guideline-based OAC.
  • Implementing such a team approach can effectively close the treatment gap in anticoagulation for NVAF patients.
Abstract

Related Concept Videos

Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
213
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
192
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.4K
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
145
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.9K
Cardiopulmonary Resuscitation III: AED Use01:23

Cardiopulmonary Resuscitation III: AED Use

Introduction to AEDAn Automated External Defibrillator (AED) is a portable medical device that analyzes the heart's rhythm and, if necessary, delivers an electrical shock to help the heart re-establish an effective rhythm during sudden cardiac arrest (SCA). SCA occurs when the heart suddenly and unexpectedly stops beating, leading to a loss of blood flow to the brain and other vital organs. In such emergencies, time is of the essence, and using an AED, combined with Cardiopulmonary...
403